Biocon Ltd
NSE:BIOCON
Biocon Ltd
Net Income (Common)
Biocon Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biocon Ltd
NSE:BIOCON
|
Net Income (Common)
₹12B
|
CAGR 3-Years
25%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
|
Net Income (Common)
-₹184.8m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
Transgene Biotek Ltd
BSE:526139
|
Net Income (Common)
-₹60.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
Net Income (Common)
₹113.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
Net Income (Common)
₹266.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Panacea Biotec Ltd
NSE:PANACEABIO
|
Net Income (Common)
-₹332.4m
|
CAGR 3-Years
44%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Biocon Ltd's Net Income (Common)?
Net Income (Common)
12B
INR
Based on the financial report for Dec 31, 2023, Biocon Ltd's Net Income (Common) amounts to 12B INR.
What is Biocon Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
8%
Over the last year, the Net Income (Common) growth was 209%. The average annual Net Income (Common) growth rates for Biocon Ltd have been 25% over the past three years , 8% over the past five years , and 8% over the past ten years .